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The impact of mammalian RNA interference compo-
nents, particularly, Argonaute proteins, on chromatin
organization is unexplored. Recent reports indicate
that AGO1 association with chromatin appears to in-
fluence gene expression. To uncover the role of
AGO1 in the nucleus, we used a combination of
genome-wide approaches in control and AGO1-
depleted HepG2 cells. We found that AGO1 strongly
associates with active enhancers and RNA being
produced at those sites. Hi-C analysis revealed
AGO1 enrichment at the boundaries of topologically
associated domains (TADs). By Hi-C in AGO1 knock-
down cells, we observed changes in chromatin
organization, including TADs and A/B compartment
mixing, specifically in AGO1-bound regions. Distinct
groups of genes and especially eRNA transcripts
located within differentially interacting loci showed
altered expression upon AGO1 depletion. Moreover,
AGO1 association with enhancers is dependent on
eRNA transcription. Collectively, our data suggest
that enhancer-associated AGO1 contributes to the
fine-tuning of chromatin architecture and gene
expression in human cells.
INTRODUCTION
Argonaute (AGO) proteins are key members of the RNA interfer-
ence (RNAi) pathway and are well documented for their role in
small RNA-mediated post-transcriptional gene silencing in the446 Cell Systems 9, 446–458, November 27, 2019 ª 2019 The Autho
This is an open access article under the CC BY license (http://creativecytoplasm (Meister, 2013; Joshua-Tor and Hannon, 2011). In
fission yeast, AGO proteins and small RNAs are essential for
heterochromatin formation (Volpe et al., 2002) and, similarly, in
plants, for RNA-dependent DNA methylation (Zilberman et al.,
2003). However, the function of RNAi components in animal
cell chromatin organization-mediated transcriptional regulation
remains unclear. We previously reported that in Drosophila,
RNAi components (dAgo2 and Dicer) are preferentially associ-
ated with active chromatin and affect transcription by regulating
RNA pol II pausing and stress response (Cernilogar et al., 2011).
Another report indicated that in Drosophila, dAgo2 associates
with insulator proteins CTCF and CP190 at active promoters
and controls looping interactions between insulators, promoters,
and enhancers (Moshkovich et al., 2011). In human cells, AGO1
binds to RNA pol II (Huang et al., 2013) to associate with active
promoters, enhancers (Allo´ et al., 2014), HP1a, and CTCF (Agirre
et al., 2015) and affects splicing (Allo´ et al., 2014; Ameyar-
Zazoua et al., 2012; Agirre et al., 2015). However, the role
of chromatin-associated AGO1 in regulating gene expression
remains to be elucidated. A study showed AGO1 binding
with RNA polymerase II and active promoters (Huang et al.,
2013), while another report indicated that AGO1 association
with active enhancers did not explain the observed widespread
changes in gene expression in AGO1 depleted cells (Allo´ et al.,
2014). In particular, it seemed important to understand whether
enhancer-associated AGO1 can directly or indirectly impact
transcription.
Enhancers are cis-regulatory elements in the mammalian
genome that orchestrate gene expression programs by direct
looping or indirect contacts with target gene promoters (Bulger
and Groudine, 2011; Ong and Corces, 2011). Enhancer loci
generally undergo bidirectional transcription by RNA pol II to
produce enhancer RNAs (eRNAs) (Natoli and Andrau, 2012).
The association of AGO1 with active enhancers was postulatedr(s). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. AGO1 Associates with Chromatin and Its Depletion Results in Deregulation of Coding and Non-coding Transcripts
(A) HepG2 cellular fractionation and western blotting using specific antibodies to detect AGO1, AGO2, AGO3, and AGO4 in different subcellular fractions
(T = total, S = soluble, and CB = chromatin bound). H3 was used as a chromatin marker.
(B) Detection of AGO1 nuclear localization in HepG2 cells, by immunofluorescence analysis. AGO1 specific antibody detects both chromatin-associated and
cytoplasmic endogenous AGO1. DAPI was used to stained nuclei (blue).(C and D) Volcano plots showing differentially expressed genes in AGO1 depleted cells,
identified byCAGE-seq analysis from chromatin associated RNAs (C) and total RNAs (D). Downregulated genes (green) and upregulated genes are shown in (red).
(E) Bar plot illustrating number of all (total and chromatin associated combined together) significant (FDR 0.05) differentially expressed coding (mRNA) and non-
coding genes.
(F) Venn diagram showing overlap of differentially expressed genes identified in total RNAs and chromatin associated RNAs by CAGE-seq analysis.
(G) Bar plot showing number significant (FDR 0.05) differentially expressed genes in each condition (total RNAs and chromatin-bound RNAs).
(legend continued on next page)
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to be mediated by enhancer RNAs (Allo´ et al., 2014). Both
enhancer elements and eRNAs are implicated in higher-order
chromatin interactions that play an essential role in gene regula-
tion (Hah et al., 2013). Recently, genome-wide chromosome
conformation capture analysis (Hi-C) has revealed that chromo-
somes are organized into active (open, A-type) and inactive
(closed, B-type) compartments (Lieberman-Aiden et al., 2009),
which are further composed of clusters of interactions called
topologically associated domains (TADs), separated by bound-
ary regions (Dixon et al., 2012; Nora et al., 2012). The 3D
chromatin structure is believed to regulate gene expression by
establishing loops between enhancers and promoters and/or
by bridging regulatory elements and genes into spatial chromatin
hubs, compartments, and domains (Bouwman and de Laat,
2015). Several chromatin regulators, including polycomb pro-
teins, cohesin, CTCF, andmediator complex have been reported
to influence 3D genome organization (Sofueva et al., 2013; Zuin
et al., 2014; Kagey et al., 2010; Seitan et al., 2013; Delest et al.,
2012). However, a potential contribution of enhancer-associated
AGO1 in three-dimensional chromatin (3D) organization has not
yet been tested.
Here, by using a combination of genome-wide approaches,
we provide evidence for an unexpected role of AGO1 in chro-
matin topological organization. We demonstrate that AGO1
binds at active chromatin regions mainly on proximal and distal
enhancers. AGO1 depletion changes the 3D genome architec-
ture leading to differential interactions, derangement of TADs
configuration, and chromatin compartments that correlate with
changes in gene expression. Collectively, these findings unveil
an unprecedented link between enhancer-associated AGO1,
the stability of higher-order chromatin architecture, and mainte-
nance of proper gene expression program in human cells.
RESULTS
AGO1 Associates with Chromatin and Its Depletion
Results in Deregulation of Coding and Non-coding
Transcripts at Genome-wide Level
To understand the function of endogenous AGO proteins inside
the nucleus, we first examined their nuclear and chromatin
association. After cellular fractionation of HepG2 cells, the west-
ern blot analysis revealed that AGO1 was more enriched
compared to AGO2-4 in the chromatin-bound fraction (Fig-
ure 1A). AGO1 nuclear distribution was further confirmed by
immunofluorescence using AGO1-specific antibody (Figure 1B).
Therefore, we focused our subsequent analysis only on AGO1
and its potential nuclear function. To evaluate the impact of
AGO1 depletion on global transcriptional changes of all
expressed TSS, we decided to use CAGE-seq analysis (Takaha-
shi et al., 2012). We knocked down AGO1 with a pool of
four siRNAs (siAGO1) and performed a control knockdown
(KD) using a non-specific scrambled siRNA (siCtrl) in HepG2
cells. The efficiency of knockdown for each individual single(H) Integration of ChIP-seq and AGO1-knockdown CAGE-seq data classify AG
expressed (DE) genes (from total and chromatin CAGE-seq combined) contain AG
not overlap with AGO1 peaks (means indirect targets).
(I) Density plot of AGO1 ChIP-seq peaks closer than 50 kb to genes (either dif
predicted by ChromHMM.
448 Cell Systems 9, 446–458, November 27, 2019siRNA was also tested. We confirmed the downregulation of
AGO1 by western blot and immunofluorescence analysis
(Figures S1A–S1C). AGO1-depleted cells showing a similar
pattern of cell viability (Figure S1D) and cell-cycle profiles
compared to control KD cells (Figure S1E) were processed for
further analysis. We then applied CAGE-seq on total and chro-
matin extracted RNA from control (siCtrl) and AGO1 depleted
(siAGO1) cells. All three replicates in each condition showed a
similar clustering pattern between themselves as represented
in PCA plot (Figure S1F). We identified more than 1,000 genes
in both total and chromatin-bound RNA CAGE-seq data that
were differentially expressed (DE) (Figures 1C–1E and for detail
see Table S1). By comparing CAGE-seq data from total RNA
and chromatin-bound RNA, we observed 171 common differen-
tially expressed genes in the two fractions (Figure 1F). Consid-
ering only the highly perturbed genes (FDR % 0.05), we found
that 512 genes were upregulated, whereas 226 genes showed
downregulation in total RNA-CAGE. Similarly, 213 upregulated
genes and 170 downregulated genes were found in CAGE
data from chromatin-bound RNAs (Figure 1G). These observa-
tions indicate that loss of AGO1 has both a positive and nega-
tive impact on gene expression (Figure 1G). We further extended
our analysis to find a possible correlation between perturbed
transcripts and deregulated miRNAs. To this, we compared
small RNA-seq data with CAGE-seq in control and AGO1-
depleted cells. The majority (95%) of perturbed mRNAs were
not direct targets of differentially expressed miRNAs (Figures
S2A–S2B). Moreover, we did not observe any good correlation
between the effect of down and upregulated miRNAs and the
expression of predicted targets (Figures S2C–S2E).
To discriminate between directly and indirectly regulated
genes, we integrated CAGE-seq with AGO1 binding sites on
chromatin (ChIP-seq). Among all the differentially expressed
genes, we observed AGO1 binding at about 29% (274) genes,
but only 16% (43) of these genes overlapped with AGO1 peaks
at their promoters. In contrast, for the majority of perturbed
genes (71%), we did not detect AGO1 at their promoters or
within the coding region (Figure 1H). However, we observed a
clear enrichment of AGO1 binding at the predicted enhancers
located within <50 kb of all the differentially expressed genes
(Figure 1I). These results suggest that AGO1 may alter predom-
inant gene expression via binding at potential distal regulatory
regions, though mechanistic aspects remained to be clarified.
The putative active enhancers are marked by bidirectional
transcription of nuclear enhancer RNAs (eRNAs) that can be de-
tected by CAGE (Andersson et al., 2014). By using chromatin
CAGE-seq data, we identified 5,538 and 3,574 putative active
eRNA loci in siCtrl and siAGO1 cells, respectively. Similarly,
from total RNA CAGE, we identified 3,574 and 4,687 CAGE-pre-
dicted eRNAs in siCtrl and siAGO1 cells, respectively. To obtain
information about eRNA dynamics upon AGO1 depletion, we
focused on 573 ( from chromatin) and 476 (from total) CAGE-
identified eRNAs that were common between siCtrl and siAGO1O1-responsive genes into direct and indirect targets. 29% of all differentially
O1 binding at their promoter or intragenically, represent direct targets. 71% do
ferentially expressed or considering all genes) centered at enhancer regions
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Figure 2. AGO1 Is Strongly Enriched at Transcriptionally Active Enhancers via RNA
(A) Pie chart representing the distribution of AGO1 ChIP-seq peaks relative to genes (located over UTRs, exons, introns, 2-kbp upstream regions [promoter-
TSSs], 1-kbp downstream regions [TTSs]). The term ‘‘non-coding’’ refers to the exons of non-coding transcripts.
(B) Heatmap showing enrichment of AGO1 ChIP-seq peaks at active enhancers (E) and promoters (TSS) determined by overlapping ChIP-seq peaks with
chromatin segmentation states (Hoffman et al., 2013) of HepG2 cells predicted by ChromHMM and Segway.
(C) Bar plot shows percent enrichment of AGO1 ChIP-seq peaks at distal, promoter, and proximal regions. AGO1 peaks are highly enriched in distal regions (i.e.,
>5 kb from nearest annotated TSS). AGO1 peaks also associate with promoter region (i.e., <1 kb from nearest annotated TSS).
(D) Density plot of ChIP-seq signals (median) of AGO1 and histone marks from ENCODE datasets including H3K4me1, H3K4me3, H3K9ac, and H3K27ac
centered at AGO1 peak located in distal, proximal, and promoter regions. AGO1-bound distal regions are enriched with active enhancer marks such as
H3K4me1, H3K27ac, and H3K4me3 representing transcriptionally active enhancers.
(E) Density of CAGE-seq signals represents transcriptional activity at AGO1-binding sites (promoter, proximal, and distal). The low level of transcriptional activity
at AGO1-enriched distal regulatory elements indicates enhancer RNAs (eRNAs).cells (for detail see Tables S2 and S3). We observed apparent
differences in the expression level (TPM values, Tags Per Million)
of eRNAs between siCtrl and siAGO1 cells (Figures S1G–S1H).
AGO1 Is Strongly Enriched at Transcriptionally Active
Enhancers via RNA
To identify AGO1 genomic distribution in humanHepG2 cells, we
performed ChIP-seq (for antibody specificity, see Figures S1A–
S1C). AGO1 ChIP-seq data analysis revealed approximately
80% mapping rate, and we identified 17,771 reproducible
AGO1-specific peaks (for detailed AGO1 ChIP peak annotation,
see Table S4). Examining the annotation of these peaks, we
found AGO1 peak distribution in genic (introns and promoters)
and inter-genic regions (Figure 2A; see Figure S3 for comparison
of AGO1 and HA-AGO1 ChIP-seq). We validated the binding of
AGO1 on selected target regions using ChIP-qPCR experimentin control and AGO1-depleted cells (Figures S4A and S4B
and for detail of primer sequence used, see Table S5). The distri-
bution of AGO1 peaks in intronic and intergenic regions (Fig-
ure 2A) may represent potential enhancers. Thus, we overlaid
AGO1 ChIP-seq peaks with the chromatin states of HepG2
cells predicted by the combination of ChromHMM and Segway.
Most represented classes were promoters and predicted
strong enhancer regions (Figure 2B). We further categorized
AGO1 peaks into three classes, i.e., promoter, proximal, and
distal regions based on distance from TSS (promoter = 1kb
up or downstream, proximal = within 5kb, and distal regions =
5kb up to 50kb). The majority of AGO1 peaks are associated
with distal regions (Figure 2C). To check that these sites are
indeed enhancers, we used publicly available ENCODE HepG2
histone ChIP-seq datasets associated with enhancer and pro-
moter regions (H3K4me1, H3K4me3, H3K27ac, and H3K9ac).Cell Systems 9, 446–458, November 27, 2019 449
AGO1-enriched promoter sites showed clear overlap with active
TSS marks (H3K27ac, H3K9ac, and H3K4me3) but not with
H3K4me1 (Figure 2D). The AGO1-bound distal regions overlap-
ped active enhancer marks such as H3K4me1, H3K27ac, and
H3K4me3 (Figure 2D). Next, by overlapping all expressed TSS
tags fromCAGE-seqwith AGO1 peaks, we observed a clear cor-
relation with RNAs produced at those sites (Figure 2E).
To clarify the involvement of RNAs in AGO1 chromatin associ-
ation, we performed cross-linked AGO1 RIP-seq from chro-
matin-bound AGO1-associated RNAs in the nucleus.We then in-
tersected all identified AGO1-associated RNA peaks (including
coding, non-coding, and un-annotated peaks) with AGO1-
bound (ChIP-seq) and -unbound chromosomal regions across
the genome. We found enrichment of RNA peaks on AGO1-
bound active sites when compared to AGO1-absent sites in
the genome (Figure 3A). We next examinedwhether RNA binding
of AGO1 contributes to its chromatin association. After chro-
matin fractionation in the presence and absence of RNase treat-
ment, the level of AGO1 protein was detected by western blot-
ting. We observed that RNase treatment highly reduced AGO1
protein level in the chromatin fraction (Figures 3B and 3C).
Thus, RNA binding stabilizes AGO1 chromatin association.
The AGO1-enriched proximal and distal regions showed a low
level of transcriptional activity that may represent putative
enhancer RNAs (eRNAs) (Figure 2E). To investigate the associa-
tion between chromatin-bound AGO1 and eRNAs, we first
examined AGO1 binding at putative eRNAs loci identified by
CAGE. We found a clear enrichment of AGO1 ChIP signals
around chromatin CAGE-defined eRNAs midpoint (Figures 3D
and 3E). We then intersected the chromatin CAGE-defined
eRNA loci with our AGO1 binding sites (ChIP peaks). Of 5,538
CAGE-identified eRNA loci, 573 putative eRNAs exactly overlap-
ped with AGO1-bound enhancer regions across the genome
(Table S6). Next, we overlaid this list of 573 putative eRNAs
with active enhancer marks H3K4me1 and H3K27ac (ENCODE
HepG2 histone ChIP) and with GRO-seq data recently published
in HepG2 cells (Bouvy-Liivrand et al., 2017). Among these, 94
CAGE-identified eRNAs overlapped with H3K4me1, H3K27ac,
and GRO-seq peaks (Table S7). To validate the requirement of
transcriptionally active eRNAs and enhancer-like long-non-cod-
ing RNAs (lncRNAs) for AGO1 enhancer association, we investi-
gated AGO1 binding on some randomly selected enhancer loci
(as defined by chromatin-CAGE, Table S7) upon inhibition of
RNA polymerase II by actinomycin D treatment. Upon transcrip-
tion inhibition, both eRNAs (sense and antisense) and AGO1
ChIP signals are significantly reduced in 9 selected CAGE-
defined enhancer regions (Figures 3F and 3G), which certify
AGO1 enrichment at transcriptionally active enhancers is medi-
ated by eRNAs.
AGO1 Depletion Alters Chromatin Interactions
Specifically in AGO1-Bound Regions
Since AGO1 binding at distal regulatory elements indirectly
impacts global gene expression, we hypothesized a role of nu-
clear AGO1 in higher-order chromatin organization. To this
scope, we performed an unbiased genome-wide chromatin
conformation analysis using Hi-C in siCtrl and siAGO1 HepG2
cells (Figure S5). At the global level, the chromosomal interac-
tion frequency heatmaps for each individual chromosome dis-450 Cell Systems 9, 446–458, November 27, 2019played similar patterns in both siAGO1 and siCtrl cells (Figures
4A and 4B). To gain deeper insight into differential interaction
frequencies between siCtrl and siAGO1 cells, we compared
normalized HiC data (siAGO1 versus siCtrl) with the R package
diffHiC (Lun and Smyth, 2015). The diffHiC analysis revealed
differences in genome-wide chromatin interactions between
siAGO1 and siCtrl cells (Figures 4C and 4D). Upon AGO1 deple-
tion, we observed extensive changes in both long-range
and short-range interaction frequency across the genome (Fig-
ures 3C and 3D). Next, we asked whether changes in chromo-
somal interactions were correlated with AGO1 binding sites.
We found that 93% of AGO1 binding sites (16,566 AGO1 peaks)
overlapped with differential interacting regions at the genome-
wide level (Figures 4E, S5F, and S5G). We then calculated the
difference in the number of differential interactions between
AGO1 enriched and without AGO1 binding 20-kb bins. We
observed significantly (t test < 0.05) higher number of differential
interactions between bin-pairs containing AGO1 binding sites
than without AGO1 binding (Figure 4F). In particular, upon
AGO1 depletion, we observed a decrease in chromosomal
interaction frequency among AGO1 binding sites, with a simulta-
neous gain in chromatin interactions at other genomic loci (Fig-
ure 4G). Overall, these data suggest that AGO1 binding at
genomic regulatory sites has influence on their higher-order
chromatin interactions.
AGO1 Depletion Perturbs Compartments and TADs
Organization at AGO1-Associated Genomic Regions
Models derived from omics data analysis (HiC) indicate that the
genome is partitioned into active (open, A-type) and inactive
(closed, B-type) compartments (Lieberman-Aiden et al., 2009;
Rao et al., 2014). Thus, we first investigated the effects of
AGO1 depletion on the A/B chromatin compartmentalization.
We defined chromatin compartments (A and B) using the first
principal component (PC1) by eigenvector analysis (Zhang
et al., 2012). To further demarcate A/B chromatin compartments,
we also intersected expressed genes (identified by CAGE-seq)
with eigenvector values. We then compared the genome-wide
compartments between siCtrl and siAGO1 cells at 100-kb reso-
lution. The siAGO1 cells displayed a highly mixed A and B
compartmentalization pattern (Figure 5A). We found that 14%
of the siAGO1 genome showed compartments switching, which
predominantly occurred in the AGO1-bound open A-type
compartment (Figures 5B and 5C).
To examine the effect on TAD organization, we first identified
3,143 and 3,593 TADs in siCtrl and siAGO1 cells, respectively,
using TADbit tool (Serra et al., 2016) (Figure 6A). Next, we as-
sessed the distribution of TADs within A/B compartments.
TADs were placed in either A or B compartment, then by
comparing siAGO1 and siCtrl genome, we found that around
12% of TADs switched from A-type to B-type compartment at
a genome-wide level (Figure 6B). We consistently found that in
siAGO1 TADs size was smaller compared to siCtrl cells (t test,
FDR < 0.05) (Figure 6C). Then, by visualizing the topological
domains in AGO1-depleted cells, we frequently observed that
larger domains found in siCtrl cells were divided into smaller
sub-domains (Figure 6D). Additionally, we found that 25% of
AGO1 binding sites (detected by ChIP-seq) overlapped with
TAD boundaries identified at 100-kb resolution (Figure 6E).
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Figure 3. AGO1 Enrichment at Active Enhancers Is Dependent on eRNA
(A) The Box plot shows enrichment of RIP-seq peaks on AGO1 binding sites (promoter, proximal, and distal regions) (Mann-Whitney test, p value 4.4e-12).
(B and C) Western blot (B) and quantitative densitometry analysis (C) shows AGO1 association with chromatin in the presence and absence of RNase A/T1
treatment. H3was used as loadingmarker. Densitometry analysis was performed from two independent experiments (as shownmean ±SD). (**p < 0.01, one-way
ANOVA Dunnett post-hoc test).
(D and E) Heatmap (D) and metagene plot (E) showing AGO1 ChIP signal enrichment around chromatin-CAGE predicted eRNA-expressing enhancer regions
(± 3kb).
(F and G) Effects of transcription inhibition in HepG2 cell by actinomycin D treatment (1.6 mM for 6 h) on the expression level (F) of CAGE-identified eRNAs or
lncRNAs and (G) AGO1 occupancy (ChIP signal) within these enhancer regions. The RNA expression level and DNA from AGO1 ChIP were quantified by qPCR (±
SD from 2 independent experiments). Primers used are listed in Table S5.
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Figure 4. AGO1 Depletion Alters Chromatin Interactions Specifically in AGO1-bound Regions
(A and B) Genome-wide chromatin conformation Hi-C analysis was performed using two replicates of siCtrl and siAGO1 cells. Representative normalized Hi-C
interaction heatmaps of chromosome 2 at 1-Mb resolution are shown in (A) siCtrl and (B) siAGO1 cells.
(C) Differential interaction heatmap for chromosome 2 (1Mb), showing upregulated (red) and downregulated (blue) interacting bins.
(D) Volcano plot representing differential interactions (DI) at 20-kb resolution. The upregulated interactions are shown in red and the downregulated interactions
are shown in green.
(E) Venn diagrams showing the number of AGO1 ChIP-seq peaks overlapping with all differential interacting bins, at 20-kb resolution.
(F) Plot showing mean number of differential interactions calculated in 20-kb bins, based on the presence and absence of overlapping AGO1 peaks at genome-
wide level (t test, p value < 0.05 and MonteCarlo permutation test (999): p value% 0.002).
(G) Genome browser snapshot showing Hi-C interaction frequency in siCtrl (green track), siAGO1 (orange track), and AGO1 ChIP-seq peaks (blue track) at
chromosome 1 locus: 12166178–117438294.Finally, although there are differences in the numbers and size of
TADs in siAGO1 cells, TAD boundaries between siCtrl and
siAGO1 cells were largely maintained (Figure 6F). These results
suggest that AGO1 binding at transcriptionally active enhancers
contribute to the maintenance of global chromatin organization
at specific genomic regions.
AGO1-Dependent Changes in 3D Genome Architecture
Are Associated with Differential Gene Expression
To determine whether AGO1-dependent changes in chromatin
topological structure correlated with differential gene expres-
sion, we applied an integrative approach by combining tran-452 Cell Systems 9, 446–458, November 27, 2019scriptome (CAGE-seq) with Hi-C and AGO1 ChIP-seq analyses.
We first examined the effect of changes in compartmentaliza-
tion on gene expression. We found that in siAGO1 cells, 20%
of differentially expressed genes were associated with disorga-
nized chromatin compartments (Figures 7A–7C). Furthermore,
the majority of deregulated genes that reside within topological
domains, or near domain borders, overlapped with extensive
changes in chromosomal interactions following AGO1 knock-
down (Figure 7D). Next, all deregulated genes (FDR % 0.05
and log2FC >1.2) located within differential interacting bins (DI
bin) were further classified into two categories based on over-
lapping with either (1) compartment switching or (2) changes
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Figure 5. Changes in A/B Chromatin Compartments upon AGO1 Knockdown
(A) Density plot showing the distribution of eigenvalues of siCtrl and siAGO1 genome at 100-kb resolution. siCtrl cells followed a bimodal distribution but not the
siAGO1 cells.
(B) Pie chart showing chromatin compartment changes between siCtrl and siAGO1 genomes. ‘‘A’’ and ‘‘B’’ represent open (active) and closed (inactive) com-
partments, respectively. ‘‘A->A’’ means no change in the compartment type between siCtrl and siAGO1 cells and remains ‘‘A’’ in both. ‘‘B->B’’ means no change
in the compartment type between siCtrl and siAGO1 cells and remains ‘‘B’’ in both. ‘‘A->B’’ represents compartments that are A-type in siCtrl but changed to
B-type in siAGO1. ‘‘B->A’’ represents compartments that are B-type in siCtrl but changed to A-type in siAGO1. Unknown represents when the compartment
status is not known either in siCtrl or in siAGO1.
(C) First eigenvector values of chromosome 1 used to define A/B chromatin compartments, positive values represent open A-type (red) and negative values
represent closed B-type (blue) compartments (top panel siCtrl and lower panel siAGO1 cells). Dotted lines delimit compartment borders. Expressed genes
represent all genes identified by CAGE-seq both non-significant (genes with a basemean expression higher than 20 but not upregulated upon AGO1 knockdown)
and significant genes (with a basemean expression higher than 20 and being upregulated for siAGO1 and downregulated for siCtrl cells).in TADs configuration (Figure 7E). Furthermore, deregulated
genes only from chromatin CAGE data were integrated with
Hi-C changes into different categories (Figures S6A and S6B).
The changes in expression of randomly selected perturbed
genes (AGO1 KD CAGE-seq) located within differentially inter-
acting bins (AGO1 KD Hi-C) were further confirmed by RT-
qPCR (Figures S6C–S6F). Altogether, around 80% of deregu-
lated genes are correlated with differential interactions (both
cis- and trans interactions) (Figures 7F and 7G), and a subset
of these genes is affected by compartment transitions (Fig-ure 7A) upon AGO1 depletion. These results suggest a role for
enhancer-associated AGO1 in maintaining proper transcrip-
tional program by contributing to chromatin topological
organization.
DISCUSSION
It has now become evident that AGO1 is present inside the nuclei
of mammalian cells and affects multiple nuclear processes,
including transcription and splicing. In this work, we report aCell Systems 9, 446–458, November 27, 2019 453
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Figure 6. AGO1 Depletion Affects TADs Configuration in AGO1-Associated Regions
(A) Number of TADs identified in siCtrl and siAGO1 cells at 40-kb resolution.
(B) Pie chart showing TADs switching between A/B compartments. ‘‘A->A’’ and ‘‘B->B’’ means no switching of TADs, they remain in the same ‘‘A’’ and ‘‘B’’
compartments, respectively. ‘‘A->B’’ represents TADs switching from A-type in siCtrl to B-type, and ‘‘B->A’’ represents TADs switching from B-type in siCtrl to
A-type in siAGO1. Unknown represents when the compartment status of TAD is not known.
(C) Box plot showing average size (kb) of TADs identified in siCtrl and siAGO1 cells, at both 40-kb and 100-kb resolution (t test p value < 0.05).
(D) Visualization of normalized Hi-C interactions from siCtrl and siAGO1 cells as two-dimensional heatmaps showing TADs in both conditions. TADs found in siCtrl
cells are often subdivided into two or more TADs in siAGO1 cells. An example from chromosome 4 (locus: 73900001–74600001) is shown.
(E) Pie chart showing the percentage of AGO1 ChIP-seq peaks localized at TAD boundaries or not.
(F) Venn diagram showing the number of overlapping TAD boundaries between siCtrl and siAGO1 cells.link between enhancer-associated AGO1, higher-order chro-
matin organization, and gene expression regulation.
In humans, there are four AGO proteins (AGO1-4) (Sasaki
et al., 2003), in which only AGO2 and AGO3 possess slicer activ-
ity (Meister et al., 2004; Park et al., 2017). Unlike AGO4, which is
mainly germline associated (Modzelewski et al., 2012), the non-
catalytic AGO1 is broadly expressed in many tissues. Currently,
it is unclear whether different AGO proteins (AGO1-4) might
play a similar function in the nucleus. AGO1 depletion appears
to increase AGO2 nuclear levels and also affect the nuclear
redistribution of other RNAi factors (Matsui et al., 2015). Our
data show that compared to AGO2-4, AGO1 proteins mostly
enrich in the chromatin fractions. Also, AGO1 and AGO2 have
been shown to display differential nuclear localization, with
AGO1 being present in the nuclear interior and AGO2 only at454 Cell Systems 9, 446–458, November 27, 2019the periphery (Huang et al., 2013). Unlike AGO1, AGO2 ChIP-
seq analysis does not detect widespread genomic distribution
(Huang et al., 2013). Notably, a recent study (van Eijl et al.,
2017) reported about the cross-reactivity of another AGO2
antibody (11A9) with SMARCC1. The same antibody was previ-
ously used for ChIP (Ameyar-Zazoua et al., 2012) and protein
immunoprecipitation (SWI/SNF) (Carissimi et al., 2015). Though
AGO2 appears to be slightly present in chromatin fraction (as de-
tected by western blot), its nuclear function and the genome-
wide association remains unclear. Any direct or indirect mecha-
nistic evidence that AGO2/3 would compensate for AGO1
nuclear function remains to be reported.
However, the absence of a functional slicing domain in AGO1
protein indicates its nuclear function to be independent of RNA-
processing, but instead, involves RNA binding, mostly ncRNA.
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Figure 7. AGO1-Dependent Changes in 3D Genome Architecture Are Linked with Differential Gene Expression
(A) Pie chart represents distribution of all differentially expressed (DE) genes (CAGE-seq) in A/B compartments between siCtrl and siAGO1 cells. ‘‘A/A’’ and ‘‘B-
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(B) Visualization of chromatin compartments A/B showing changes between siCtrl and siAGO1 cells (chromosome 1).
(C) Genome browser snapshot showing differentially expressed genes in the same region of chromosome 1 as in (B), upregulated in red and downregulated in
blue (threshold FDR 0.05).
(legend continued on next page)
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The mechanistic explanation of the impact of AGO1 deple-
tion on higher-order chromatin organization remains to be
understood. The role of RNA as an essential component of
nuclear structure has been recognized for a long time (Nicker-
son et al., 1989; Holmes et al., 1972). Emerging evidence
in the field of 3D genome architecture highlights the involve-
ment of non-coding RNAs (ncRNA) in this process (Mele´ and
Rinn, 2016; Yang et al., 2013; Cerase et al., 2015; Hacisuley-
man et al., 2014). Our RIP-seq analysis in HepG2 cells identi-
fied a plethora of ncRNA moieties that are associated with
chromatin-bound AGO1 and overlapped with its binding sites
across the genome. Therefore, we anticipate that the RNA
targets coordinating in AGO1 nuclear function are more than
one. Genome-wide binding of AGO1 at transcriptionally active
enhancers may suggest its role in shaping chromatin structure
and gene expression by coordinating with ncRNAs, particu-
larly eRNAs. Enhancer regions are often transcribed in a
bidirectional manner by RNA polymerase II and produce
eRNAs (Kim et al., 2010). The eRNAs have been shown to
be involved in gene regulation by different mechanism such
as controlling enhancer looping interactions (Hsieh et al.,
2014; Hah et al., 2011), chromatin accessibility (Mousavi
et al., 2013), and their direct interaction with CBP control
enhancer activity and transcription (Bose et al., 2017). AGO1
has been shown to interact with RNA pol II across active en-
hancers (Huang et al., 2013; Allo´ et al., 2014) and may be
required for eRNAs transcription. Indeed, upon AGO1 deple-
tion, we observed obvious changes in the expression level
of CAGE-defined eRNAs. These CAGE-identified eRNAs
are produced from AGO1-bound enhancer regions. Moreover,
the enrichment of AGO1 at active cis-regulatory elements
depends on eRNAs expression, suggesting eRNAs function
as a potential bridge between AGO1, chromatin association,
and gene expression. AGO1, in association with eRNAs
might control enhancer activity that could contribute to
higher-order chromatin organization. AGO1, being a strong
RNA binding protein, may play a role in establishing protein-
RNA networks inside the nucleus that are essential for the
stability of cell type-specific gene expression programs.
Future work will, therefore, be required to investigate the
mechanistic functional link between enhancer-associated
AGO1 and eRNAs in the control of 3D genome organization
and gene expression homeostasis.STAR+METHODS
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and include the following:(D) A representative plot of chromosome 12 showing (1) differential interactions up-int
in siCtrl and siAGO1 cells (100-kb resolution), and (3) compartments in siCtrl and siA
downregulated in brown (threshold FDR 0.05). The vertical dotted lines reflect comp
(E) Bar plot showing classification of differentially expressed genes into two catego
contains the number of DE genes (FDR threshold 0.05) overlapping with AGO1-bou
configuration (DI bin + Diff.TAD), and/or compartment switching (DI bin + Comp) bet
(F and G) CIRCOS plot illustrating the position of significant intra- (F) and inter- (G) c
interacting regions are linked by blue lines while the up-interacting bins are linked b
1.Chromosome names, 2.DE genes (FDR 0.05; upregulated genes [red] downregula
456 Cell Systems 9, 446–458, November 27, 2019d KEY RESOURCES TABLE
d LEAD CONTACT AND MATERIALS AVAILABILITY
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
B Cell Lines
d METHOD DETAILS
B Cell Culture and Transfection
B Antibodies
B Chromatin Fractionation and Western Blot
B Immunofluorescence
B nanoCAGE-seq
B ChIP-seq
B Stable FLAG- HA-tagged AGO1 HepG2 Cell Lines
B AGO1 RIP from Chromatin Fraction
B RT-qPCR
B Preparation of Hi-C Libraries and Generation of Con-
tact Matrices
B Small RNA-seq
B Bioinformatics Analyses
B ChIP-seq Data Analysis
B Hi-C Data Analysis
d QUANTIFICATION AND STATISTICAL ANALYSIS
d DATA AND CODE AVAILABILITYSUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.
cels.2019.09.005.ACKNOWLEDGMENTS
We are grateful to Hakan Ozadam and Johan Gibcus from Job Dekker group
(University of Massachusetts Medical School, USA) for initial help in calling Hi-
C interactions, Riccardo Aiese Cigliano (Sequentia Biotech) for bioinformatic
analysis, and Heno Hwang (scientific illustrator) at King Abdullah University
of Science and Technology (KAUST) for his help in drawing the graphical ab-
stract. This work was supported by EPIGEN-CNR (Italian Ministry of University
and Research) and King Abdullah University of Science and Technology
(KAUST) to V.O.AUTHOR CONTRIBUTIONS
M.S. conceived this study, designed and performed experiments, analyzed
the data, and wrote the manuscript with input from all the authors. K.M.P.
conceived this study, designed, performed experiments, and analyzed the
data. S.A.A. with M.S. performed Hi-C experiments. M.T. and H.K. performed
computational analyses of CAGE-seq and ChIP-seq data. L.S. and T.R. per-
formed computational analyses of ChIP-seq and CAGE-seq data integration.
Y.G. performed computational analyses of RIP-seq and ChIP-seq integration.
A.F. contributed in RIP-seq experiments. B.F. helped in western blotting. P.C.
and H.K. produced and analyzed the CAGE-seq experiment. V.O. conceived
this study, designed experiments, and wrote the manuscript.eracting bins (red) and down-interacting bins (blue), (2) TADs configuration
GO, and (4) differentially expressed genes with upregulated in purple and
artment switching between siCtrl and siAGO1 cells.
ries based on integration with AGO1 ChIP-seq and Hi-C data. This plot
nd differentially interacting bins that either associate with different TADs
ween siCtrl and siAGO1 cells.
hromosomal differential interactions (FDR < 0.001 and logFC > 3), down-
y orange lines. The three circles in the plot represent the following data;
ted genes [blue]), 3.AGO1 ChIP-seq peaks (green).
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: April 1, 2019
Revised: July 29, 2019
Accepted: September 12, 2019
Published: October 16, 2019REFERENCES
Agirre, E., Bellora, N., Allo´, M., Page`s, A., Bertucci, P., Kornblihtt, A.R., and
Eyras, E. (2015). A chromatin code for alternative splicing involving a putative
association between CTCF and HP1alpha proteins. BMC Biol. 13, 31.
Allo´, M., Agirre, E., Bessonov, S., Bertucci, P., Go´mez Acun˜a, L., Buggiano, V.,
Bellora, N., Singh, B., Petrillo, E., Blaustein, M., et al. (2014). Argonaute-1 binds
transcriptional enhancers and controls constitutive and alternative splicing in
human cells. Proc. Natl. Acad. Sci. USA 111, 15622–15629.
Ameyar-Zazoua, M., Rachez, C., Souidi, M., Robin, P., Fritsch, L., Young, R.,
Morozova, N., Fenouil, R., Descostes, N., Andrau, J.C., et al. (2012). Argonaute
proteins couple chromatin silencing to alternative splicing. Nat. Struct. Mol.
Biol. 19, 998–1004.
Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd,
M., Chen, Y., Zhao, X., Schmidl, C., Suzuki, T., et al. (2014). An atlas of active
enhancers across human cell types and tissues. Nature 507, 455–461.
Ashoor, H., He´rault, A., Kamoun, A., Radvanyi, F., Bajic, V.B., Barillot, E., and
Boeva, V. (2013). HMCan: a method for detecting chromatin modifications in
cancer samples using ChIP-seq data. Bioinformatics 29, 2979–2986.
Babicki, S., Arndt, D., Marcu, A., Liang, Y.J., Grant, J.R., Maciejewski, A., and
Wishart, D.S. (2016). Heatmapper: web-enabled heat mapping for all. Nucleic
Acids Res. 44, W147–W153.
Belton, J.M., Mccord, R.P., Gibcus, J.H., Naumova, N., Zhan, Y., and Dekker,
J. (2012). Hi-C: a comprehensive technique to capture the conformation of
genomes. Methods 58, 268–276.
Bose, D.A., Donahue, G., Reinberg, D., Shiekhattar, R., Bonasio, R., and
Berger, S.L. (2017). RNA binding to CBP stimulates histone acetylation and
transcription. Cell 168, 135–149.
Bouvy-Liivrand, M., Herna´ndez de Sande, A., Po¨lo¨nen, P., Mehtonen, J.,
Vuorenmaa, T., Niskanen, H., Sinkkonen, L., Kaikkonen, M.U., and
Hein€aniemi, M. (2017). Analysis of primary microRNA loci from nascent tran-
scriptomes reveals regulatory domains governed by chromatin architecture.
Nucleic Acids Res. 45, 12054.
Bouwman, B.A., and de Laat, W. (2015). Getting the genome in shape: the for-
mation of loops, domains and compartments. Genome Biol. 16, 154.
Bulger, M., and Groudine, M. (2011). Functional and mechanistic diversity of
distal transcription enhancers. Cell 144, 825.
Carissimi, C., Laudadio, I., Cipolletta, E., Gioiosa, S., Mihailovich, M., Bonaldi,
T., Macino, G., and Fulci, V. (2015). ARGONAUTE2 cooperates with SWI/SNF
complex to determine nucleosome occupancy at human transcription start
sites. Nucleic Acids Res. 43, 1498–1512.
Cerase, A., Pintacuda, G., Tattermusch, A., and Avner, P. (2015). Xist localiza-
tion and function: new insights from multiple levels. Genome Biol. 16, 166.
Cernilogar, F.M., Onorati, M.C., Kothe, G.O., Burroughs, A.M., Parsi, K.M.,
Breiling, A., Lo Sardo, F., Saxena, A., Miyoshi, K., Siomi, H., et al. (2011).
Chromatin-associated RNA interference components contribute to transcrip-
tional regulation in Drosophila. Nature 480, 391–395.
Chou, C.H., Shrestha, S., Yang, C.D., Chang, N.W., Lin, Y.L., Liao, K.W.,
Huang, W.C., Sun, T.H., Tu, S.J., Lee, W.H., et al. (2018). miRTarBase update
2018: a resource for experimentally validated microRNA-target interactions.
Nucleic Acids Res. 46, D296–D302.
Delest, A., Sexton, T., and Cavalli, G. (2012). Polycomb: a paradigm for
genome organization from one to three dimensions. Curr. Opin. Cell Biol. 24,
405–414.Dixon, J.R., Selvaraj, S., Yue, F., Kim, A., Li, Y., Shen, Y., Hu, M., Liu, J.S., and
Ren, B. (2012). Topological domains in mammalian genomes identified by
analysis of chromatin interactions. Nature 485, 376–380.
Hacisuleyman, E., Goff, L.A., Trapnell, C., Williams, A., Henao-Mejia, J., Sun,
L., Mcclanahan, P., Hendrickson, D.G., Sauvageau, M., Kelley, D.R., et al.
(2014). Topological organization of multichromosomal regions by the long in-
tergenic noncoding RNA Firre. Nat. Struct. Mol. Biol. 21, 198–206.
Hah, N., Danko, C.G., Core, L., Waterfall, J.J., Siepel, A., Lis, J.T., and Kraus,
W.L. (2011). A rapid, extensive, and transient transcriptional response to estro-
gen signaling in breast cancer cells. Cell 145, 622–634.
Hah, N., Murakami, S., Nagari, A., Danko, C.G., and Kraus, W.L. (2013).
Enhancer transcripts mark active estrogen receptor binding sites. Genome
Res. 23, 1210–1223.
Harrow, J., Frankish, A., Gonzalez, J.M., Tapanari, E., Diekhans, M.,
Kokocinski, F., Aken, B.L., Barrell, D., Zadissa, A., Searle, S., et al. (2012).
GENCODE: the reference human genome annotation for the ENCODE
Project. Genome Res. 22, 1760–1774.
Hoffman, M.M., Ernst, J., Wilder, S.P., Kundaje, A., Harris, R.S., Libbrecht, M.,
Giardine, B., Ellenbogen, P.M., Bilmes, J.A., Birney, E., et al. (2013). Integrative
annotation of chromatin elements from ENCODE data. Nucleic Acids Res. 41,
827–841.
Holmes, D.S., Mayfield, J.E., Sander, G., and Bonner, J. (1972). Chromosomal
RNA: its properties. Science 177, 72–74.
Hsieh, C.L., Fei, T., Chen, Y.W., Li, T.T., Gao, Y.F., Wang, X.D., Sun, T.,
Sweeney, C.J., Lee, G.S.M., Chen, S.Y., et al. (2014). Enhancer RNAs partic-
ipate in androgen receptor-driven looping that selectively enhances gene acti-
vation. Proc. Natl. Acad. Sci. USA 111, 7319–7324.
Huang, V., Zheng, J., Qi, Z., Wang, J., Place, R.F., Yu, J., Li, H., and Li, L.C.
(2013). Ago1 Interacts with RNA polymerase II and binds to the promoters of
actively transcribed genes in human cancer cells. PLoS Genet. 9, e1003821.
Joshua-Tor, L., and Hannon, G.J. (2011). Ancestral roles of small RNAs: an
Ago-centric perspective. Cold Spring Harb. Perspect. Biol. 3, a003772.
Kagey, M.H., Newman, J.J., Bilodeau, S., Zhan, Y., Orlando, D.A., Van
Berkum, N.L., Ebmeier, C.C., Goossens, J., Rahl, P.B., Levine, S.S., et al.
(2010). Mediator and cohesin connect gene expression and chromatin archi-
tecture. Nature 467, 430–435.
Kim, T.K., Hemberg, M., Gray, J.M., Costa, A.M., Bear, D.M., Wu, J., Harmin,
D.A., Laptewicz, M., Barbara-Haley, K., Kuersten, S., et al. (2010). Widespread
transcription at neuronal activity-regulated enhancers. Nature 465, 182–187.
Kumar, D., Shadrach, J.L., Wagers, A.J., and Lassar, A.B. (2009). Id3 is a direct
transcriptional target of Pax7 in quiescent satellite cells. Mol. Biol. Cell 20,
3170–3177.
Langmead, B., and Salzberg, S.L. (2012). Fast gapped-read alignment with
Bowtie 2. Nat. Methods 9, 357–359.
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G.,
Abecasis, G., and Durbin, R.; 1000 Genome Project Data Processing
Subgroup (2009). The sequence alignment/map format and SAMtools.
Bioinformatics 25, 2078–2079.
Li, Q.H., Brown, J.B., Huang, H.Y., and Bickel, P.J. (2011). Measuring repro-
ducibility of high-throughput experiments. Ann. Appl. Stat. 5, 1752–1779.
Lieberman-Aiden, E., Van Berkum, N.L., Williams, L., Imakaev, M., Ragoczy,
T., Telling, A., Amit, I., Lajoie, B.R., Sabo, P.J., Dorschner, M.O., et al.
(2009). Comprehensive mapping of long-range interactions reveals folding
principles of the human genome. Science 326, 289–293.
Lun, A.T., and Smyth, G.K. (2015). diffHic: a bioconductor package to detect
differential genomic interactions in Hi-C data. BMC Bioinformatics 16, 258.
Matsui, M., Li, L.D., Janowski, B.A., and Corey, D.R. (2015). Reduced expres-
sion of Argonaute 1, Argonaute 2, and TRBP changes levels and intracellular
distribution of RNAi factors. Sci. Rep. 5, 12855.
Meister, G. (2013). Argonaute proteins: functional insights and emerging roles.
Nat. Rev. Genet. 14, 447–459.
Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., and
Tuschl, T. (2004). Human Argonaute2 mediates RNA cleavage targeted by
miRNAs and siRNAs. Mol. Cell 15, 185–197.Cell Systems 9, 446–458, November 27, 2019 457
Mele´, M., and Rinn, J.L. (2016). "Cat’s Cradling’ the 3D genome by the act of
LncRNA transcription. Mol. Cell 62, 657–664.
Modzelewski, A.J., Holmes, R.J., Hilz, S., Grimson, A., and Cohen, P.E. (2012).
AGO4 regulates entry into meiosis and influences silencing of sex chromo-
somes in the male mouse germline. Dev. Cell 23, 251–264.
Moshkovich, N., Nisha, P., Boyle, P.J., Thompson, B.A., Dale, R.K., and Lei,
E.P. (2011). RNAi-independent role for Argonaute2 in CTCF/CP190 chromatin
insulator function. Genes Dev. 25, 1686–1701.
Mousavi, K., Zare, H., Dell’Orso, S., Grontved, L., Gutierrez-Cruz, G., Derfoul,
A., Hager, G.L., and Sartorelli, V. (2013). eRNAs promote transcription by es-
tablishing chromatin accessibility at defined genomic loci. Mol. Cell 51,
606–617.
Natoli, G., and Andrau, J.C. (2012). Noncoding transcription at enhancers:
general principles and functional models. Annu. Rev. Genet. 46, 1–19.
Neph, S., Kuehn, M.S., Reynolds, A.P., Haugen, E., Thurman, R.E., Johnson,
A.K., Rynes, E., Maurano, M.T., Vierstra, J., Thomas, S., et al. (2012).
BEDOPS: high-performance genomic feature operations. Bioinformatics 28,
1919–1920.
Nickerson, J.A., Krochmalnic, G., Wan, K.M., and Penman, S. (1989).
Chromatin architecture and nuclear-RNA. Proc. Natl. Acad. Sci. USA 86,
177–181.
Nora, E.P., Lajoie, B.R., Schulz, E.G., Giorgetti, L., Okamoto, I., Servant, N.,
Piolot, T., Van Berkum, N.L., Meisig, J., Sedat, J., et al. (2012). Spatial partition-
ing of the regulatory landscape of the X-inactivation centre. Nature 485,
381–385.
Ong, C.T., and Corces, V.G. (2011). Enhancer function: new insights into the
regulation of tissue-specific gene expression. Nat. Rev. Genet. 12, 283–293.
Park, M.S., Phan, H.D., Busch, F., Hinckley, S.H., Brackbill, J.A., Wysocki,
V.H., and Nakanishi, K. (2017). Human Argonaute3 has slicer activity.
Nucleic Acids Res. 45, 11867–11877.
Pohl, A., and Beato, M. (2014). bwtool: a tool for bigWig files. Bioinformatics
30, 1618–1619.
Quinlan, A.R., and Hall, I.M. (2010). BEDTools: a flexible suite of utilities for
comparing genomic features. Bioinformatics 26, 841–842.
Rahman, R.U., Gautam, A., Bethune, J., Sattar, A., Fiosins, M., Magruder,
D.S., Capece, V., Shomroni, O., and Bonn, S. (2018). Oasis 2: improved online
analysis of small RNA-seq data. BMC Bioinformatics 19, 54.
Rao, S.S.P., Huntley, M.H., Durand, N.C., Stamenova, E.K., Bochkov, I.D.,
Robinson, J.T., Sanborn, A.L., Machol, I., Omer, A.D., Lander, E.S., et al.
(2014). A 3D map of the human genome at kilobase resolution reveals princi-
ples of chromatin looping. Cell 159, 1665–1680.
Salimullah, M., Sakai, M., Plessy, C., and Carninci, P. (2011). NanoCAGE: a
high-resolution technique to discover and interrogate cell transcriptomes.
Cold Spring Harb. Protoc. 2011, pdb.prot5559.
Sasaki, T., Shiohama, A., Minoshima, S., and Shimizu, N. (2003). Identification
of eight members of the Argonaute family in the human genome. Genomics 82,
323–330.
Schoenfelder, S., Furlan-Magaril, M., Mifsud, B., Tavares-Cadete, F., Sugar,
R., Javierre, B.M., Nagano, T., Katsman, Y., Sakthidevi, M., Wingett, S.W.,458 Cell Systems 9, 446–458, November 27, 2019et al. (2015). The pluripotent regulatory circuitry connecting promoters to their
long-range interacting elements. Genome Res. 25, 582–597.
Seitan, V.C., Faure, A.J., Zhan, Y., Mccord, R.P., Lajoie, B.R., Ing-Simmons,
E., Lenhard, B., Giorgetti, L., Heard, E., Fisher, A.G., et al. (2013). Cohesin-
based chromatin interactions enable regulated gene expression within preex-
isting architectural compartments. Genome Res. 23, 2066–2077.
Serra, F., Bau, D., Filion, G., andMarti-Renom,M.A. (2016). Structural features
of the fly chromatin colors revealed by automatic three-dimensional modeling.
bioRxiv. https://doi.org/10.1101/036764.
Serra, F., Bau, D., Goodstadt, M., Castillo, D., Filion, G.J., and Marti-Renom,
M.A. (2017). Automatic analysis and 3D-modelling of Hi-C data using TADbit
reveals structural features of the fly chromatin colors. PLoS Comput. Biol.
13, e1005665.
Servant, N., Varoquaux, N., Lajoie, B.R., Viara, E., Chen, C.J., Vert, J.P., Heard,
E., Dekker, J., and Barillot, E. (2015). HiC-Pro: an optimized and flexible pipe-
line for Hi-C data processing. Genome Biol. 16, 259.
Sofueva, S., Yaffe, E., Chan, W.C., Georgopoulou, D., Vietri Rudan, M., Mira-
Bontenbal, H., Pollard, S.M., Schroth, G.P., Tanay, A., and Hadjur, S. (2013).
Cohesin-mediated interactions organize chromosomal domain architecture.
EMBO J. 32, 3119–3129.
Takahashi, H., Lassmann, T., Murata, M., and Carninci, P. (2012). 5 0 End-
centered expression profiling using cap-analysis gene expression and next-
generation sequencing. Nat. Protoc. 7, 542–561.
Uren, P.J., Bahrami-Samani, E., Burns, S.C., Qiao, M., Karginov, F.V., Hodges,
E., Hannon, G.J., Sanford, J.R., Penalva, L.O.F., and Smith, A.D. (2012). Site
identification in high-throughput RNA-protein interaction data.
Bioinformatics 28, 3013–3020.
van Eijl, R.A.P.M., Van Den Brand, T., Nguyen, L.N., and Mulder, K.W. (2017).
Reactivity of human AGO2monoclonal antibody 11A9 with the SWI/SNF com-
plex: a case study for rigorously defining antibody selectivity. Sci. Rep.
7, 7278.
Volpe, T.A., Kidner, C., Hall, I.M., Teng, G., Grewal, S.I., and Martienssen, R.A.
(2002). Regulation of heterochromatic silencing and histone H3 lysine-9
methylation by RNAi. Science 297, 1833–1837.
Yang, L.Q., Lin, C.R., Jin, C.Y., Yang, J.C., Tanasa, B., Li, W.B., Merkurjev, D.,
Ohgi, K.A., Meng, D., Zhang, J., et al. (2013). lncRNA-dependent mechanisms
of androgen-receptor-regulated gene activation programs. Nature 500,
598–602.
Zhang, Y., Mccord, R.P., Ho, Y.J., Lajoie, B.R., Hildebrand, D.G., Simon, A.C.,
Becker, M.S., Alt, F.W., and Dekker, J. (2012). Spatial organization of the
mouse genome and its role in recurrent chromosomal translocations. Cell
148, 908–921.
Zilberman, D., Cao, X., and Jacobsen, S.E. (2003). ARGONAUTE4 control of
locus-specific siRNA accumulation and DNA and histone methylation.
Science 299, 716–719.
Zuin, J., Dixon, J.R., Van Der Reijden, M.I., Ye, Z., Kolovos, P., Brouwer, R.W.,
VanDeCorput,M.P., Van DeWerken, H.J., Knoch, T.A., van IJcken,W.F., et al.
(2014). Cohesin and CTCF differentially affect chromatin architecture and gene
expression in human cells. Proc. Natl. Acad. Sci. USA 111, 996–1001.
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse monoclonal anti-AGO1 (Clone#2A7) Wako 015-22411; RRID: AB_2096179
Mouse monoclonal anti-AGO1 sup Gift (Mikiko Siomi) N/A
Rabbit Anti-Argonaute 2 Monoclonal
Antibody (Clone C34C6)
Cell Signaling Technology 2897; RRID: AB_2096291
Argonaute 3 (D15D2) Rabbit mAb antibody Cell Signaling Technology 5054; RRID: AB_2797607
Argonaute 4 (D10F10) Rabbit mAb antibody Cell Signaling Technology 6913; RRID: AB_10828811
b-Tubulin antibody Cell Signaling Technology Cat# 2146; RRID: AB_2210545
Histone H3 antibody Cell Signaling Technology Cat# 9715; RRID: AB_331563
HA tag antibody - ChIP Grade Abcam ab9110; RRID: AB_307019
Alexa flour 647 Abcam Cat# ab150115; RRID: AB_2687948
Chemicals, Peptides, and Recombinant Proteins
Protein G Dynabeads ThermoFisher 10003D
Ampure XP paramagnetic beads Beckman Coulter A63881
Complete Mini EDTA-free proteinase
inhibitor
Roche 11836170001
HindIII New England Biolabs R0104S
T4 DNA ligase New England Biolabs M0202S
Dynabeads M-280 streptavidin ThermoFisher 11206D
Biotin-14-dATP ThermoFisher 19524016
RNase A Thermo Fisher EN0531
RNase A/T1 Mix Thermo Fisher EN0551
Proteinase K New England Biolabs P8107S
TRIzol reagent Thermo Fisher 15596026
AlamarBlue Dye Thermo Fisher DAL1025
Critical Commercial Assays
ChIP DNA Clean & Concentrator Zymo Research D5205
QuantiTect Reverse Transcription Kit Qiagen 205311
Direct-zol RNA Miniprep Zymo Research R2050
Qubit dsDNA HS Assay Kit ThermoFisher Q32854
Qubit RNA HS Assay Kit ThermoFisher Q32852
TruSeq Small RNA Library Prep Kit Illumina RS-200-0012
TruSeq Stranded Total RNA Library Prep Illumina 20020596
TruSeq ChIP Library Preparation Kit Illumina IP-202-1012
Deposited Data
CAGE-seq (Chromatin and Total RNA in
siCtrl, siAGO1 and control HepG2 cells)
This study SRA: PRJNA398595
AGO1 ChIP-seq (HepG2) This study SRA: PRJNA398595
Small RNA-seq (siCtrl and siAGO1
HepG2 cells)
This study SRA: PRJNA398595
Hi-C-seq (siCtrl and siAGO1 HepG2 cells) This study SRA: PRJNA398595
AGO1 RIP-seq (HepG2) This study SRA: PRJNA543746
AGO1 and HA-AGO1 comparison-test
ChIP-seq
This study SRA: PRJNA543746
GRO-seq (HepG2) (Bouvy-Liivrand et al., 2017) GEO: GSE92375
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
H3K27ac, H3K4me1, H3K4me3, and
H3K9ac ChIP-seq (HepG2)
https://www.encodeproject.org/ GEO: GSE29611
Chromatin segmentations (HepG2) (Hoffman et al., 2013) ENCODE Genome Segmentation
Experimental Models: Cell Lines
HepG2 ATCC HB-8065
HEK 293T ATCC CRL-3216
Oligonucleotides
Oligo DNA primers for RT-qPCR, ChIP-
qPCR, and siRNA information
Table S5 N/A
Recombinant DNA
Plasmid: pOZ-FH-C-puro, retroviral vector
(Used for expressing HA-FLAG-tagged
AGO1)
A kind gift from Andrew Lassar
(Kumar et al., 2009)
Addgene plasmid # 32516, RRID:
Addgene_32516
Software and Algorithms
Small RNA-seq analysis tool Oasis 2.0 (Rahman et al., 2018) https://oasis.dzne.de
mirTarBase tool (Chou et al., 2018) mirtarbase.mbc.nctu.edu.tw/php/
Cutadapt 1.12 (https://github.com/marcelm/cutadapt/ https://github.com/marcelm/cutadapt/
R package CAGEr https://bioconductor.org/packages/
release/bioc/html/CAGEr.html
https://bioconductor.org/packages/
release/bioc/html/CAGEr.html
Bioconductor package DESeq2 https://bioconductor.org/packages/
release/bioc/html/DESeq2.html
https://bioconductor.org/packages/
release/bioc/html/DESeq2.html
Sickle http://www.citeulike.org/user/
mvermaat/article/13260426
http://www.citeulike.org/user/mvermaat/
article/13260426
Bowtie (Langmead and Salzberg, 2012) Version 2.2.5
Samtools (Li et al., 2009) Version 1.2
HMCan peak calling tool (Ashoor et al., 2013) N/A
Irreproducibility Discovery Rate (IDR)
analysis
(Li et al., 2011) N/A
Bedtools (Quinlan and Hall, 2010) N/A
BEDOPS (Neph et al., 2012) N/A
bwtools (Pohl and Beato, 2014) Version 2.17
HiC-Pro pipeline (Servant et al., 2015) Version 2.7.8
R package diffHiC (Lun and Smyth, 2015) Version 1.6.0
TADbit (Serra et al., 2017) Version 0.2.0.23
HiCExplorer http://hicexplorer.readthedocs.
io/en/latest/index.html
Version 1.3
Piranha (Uren et al., 2012) Version 1.2.1
Heatmapper (Babicki et al., 2016) N/A
Other
GENCODE v19 GENCODE
(Harrow et al., 2012)
https://www.gencodegenes.org/releases/
19.htmlLEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact (valerio.orlando@kaust.
edu.sa). This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines
HepG2 (ATCC, HB-8065, male) and HEK-293 (ATCC, CRL-3216, female) cells were purchased from ATCC before experiments and
thus considered authenticated.e2 Cell Systems 9, 446–458.e1–e6, November 27, 2019
METHOD DETAILS
Cell Culture and Transfection
HepG2 and HEK-293 cells were cultured in EMEM medium (Sigma, Cat # M0643) supplemented with 10% FBS (Invitrogen, Cat #
26140-079) 1% penicillin and streptomycin (Euroclone, Cat # ECB3001D). Cell culture was maintained at 37C and 5% CO2.
HepG2 cells were transiently transfected with a pool of four siRNAs against AGO1 (FlexiTube GeneSolution GS26523, cat#
SI00377454, SI00377447, SI00377440, and SI00377433) by using HiPerfect reagent (Qiagen). After 48hrs of incubation, cells
were harvested for further analysis. Cell viability was assessed using alamarBlue cell viability reagent (Cat# DAL1025) according
to the manufacture’s instructions. For flow cytometry, cells were pelleted and fixed in ice cold 70% ethanol. After fixation the cell
pellet was resuspended in the PI staining solution (0.1% Triton X-100, 10 mg/mL propidium iodide and 100 mg/mL RNase A). Cell-cy-
cle analysis was performed using BD FACSCanto II system and experiments were repeated three times.
Antibodies
Mousemonoclonal anti-AGO1 sup (Mikiko Siomi) anti-AGO1 (clone 2A7,Wako), b-tubulin antibody (#2146, Cell Signaling), and rabbit
monoclonal histone H3 antibody (#9715, Cell Signaling), anti-AGO-2 (#2897 Cell Signaling), anti-AGO3 (#5054 Cell Signaling), and
anti-AGO4 (#6913 Cell Signaling) were used as primary antibody for western blotting or immunofluorescence. Alexa flour 647
Goat anti-mouse IgG (H+L) (ab150115, Abcam) was used as secondary antibody for immunofluorescence. Mouse monoclonal
anti-AGO1 (clone 2A7, Wako) and rabbit polyclonal HA-tag antibody (Abcam, # ab9110) for ChIP experiment. Anti-AGO1 (clone
2A7, Wako) was used for control validation by ChIP-qPCR, western blot, and immunofluorescence.
Chromatin Fractionation and Western Blot
Cells were lysed in RIPA buffer (10 mM Tris pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% Sodium deoxycholate, 0.1%
SDS, 150 mM EDTA and 0.5 mM PMSF, 10 U/ml Superase-In, 1X Protease inhibitor cocktail), incubated for 30 minutes on ice, and
spun at 13000 rpm for 10 min to collect supernatant as total fraction (T). For chromatin fractionation, cells were lysed in CSKI buffer
(10 mMPipes pH 6.8, 100 mMNaCl, 1 mM EDTA, 300 mMSucrose, 1 mMMgCl2, 1 mMDTT, 0.5% Triton X-100, 10 U/ml Superase-
In, 1X Protease inhibitor cocktail) for 15 min on ice (vortexed occasionally) and spun at 3000 rpm for 5 min to remove the soluble
fraction (S). Pellet was resuspended in CSK II buffer (10 mM Pipes pH 6.8, 50 mM NaCl, 300 mM Sucrose, 6 mM MgCl2, 1mM
DTT), treated with DNase I (Promega, M610A) for 25 min at 30C, and followed by extraction with 250 mM (NH4)2SO4 for 10 min.
The extract was centrifuged at 1200g for 10 min at 4C to collect the supernatant as chromatin bound fraction (CB). Protein samples
from all fractions were denatured in 1X Laemmli buffer (100mM DTT) and separated on 4-12% gradient Bis-Tris gels (NuPAGE), and
then transferred onto a nitrocellulose membrane (GE Healthcare) for 2 hours. The membrane was blocked with 5% milk in PBST,
incubated in primary antibody overnight, washed with PBST, and incubated with secondary antibody for 1 hour. Western-blot signals
were visualized using ECL Reagent (Amersham) and ChemiDoc Imaging System (Bio-Rad).
For chromatin association assay in the presence of RNAse, the pellet obtained after soluble fraction (S) was divided into two frac-
tions. The first half fraction was treated with 15ul of RNaseA/T1 (Ambion, AM2275); the other half was treated with same volume of
RNase storage buffer (50mM Tris pH 7.4, 300mM NaCl, 0.5% NP-40, 1mM EDTA) at room temperature for 30 minutes and then fol-
lowed the chromatin extraction steps as mentioned above. Band intensities from two independent chromatin fractionation assays
were quantified using Image Lab software (ChemiDoc, BioRad).
Immunofluorescence
HepG2 cells were fixed with 4% formaldeyhyde for AGO1 staining. Immunofluorescence was performed according to standard pro-
cedure. Images were acquired by using confocal microscope (Zeiss).
nanoCAGE-seq
After cellular fractionation of HepG2 cells as described above, the total and chromatin bound fraction samples were addedwith Trizol
for RNA extraction. The RNA purification was performed with Direct-zol RNA Miniprep kit (ZymoResearch) and then quantified by
quibit (Qubit RNA HS Assay Kit). Samples were processed for nanoCAGEseq as described earlier (Salimullah et al., 2011).
ChIP-seq
HepG2 cells were cross-linked with 2% formaldehyde on shaking platform for 12 min at room temperature. The reaction was
quenchedwith 125mMof glycine, and cells were collected by scraping. The pellet was further processed by incubating in lysis buffer
(5 mMHEPES/KOH pH 8.0, 85 mMKCl, 0.5%NP-40, 0.5 mM PMSF) for 30 min on ice. Pelleted nuclei were resuspended in shearing
buffer (50mM Tris/HCl pH 8.0, 1mMEDTA, 0.1%SDS, 0.5%DOC, 0.5 mMPMSF), passed through 1ml syringe for 10-15 times, and
sonicatedwith Diagenode Bioruptor (total 3 cycles for 7min eachwith settings 30 secON and 30 secOFF atmaximumamplitude). To
remove debris, sonicated samples were spun at 16000xg for 20 min at 4C. Supernatant was collected and chromatin DNA fragment
size (average 500 bp) was checked after decrosslinking at 65C for 4 hrs on 2% agarose gel. Chromatin suspension was mixed with
1X IP buffer (1mMTris/HCl pH 7.4, 0.1mMEDTA, 0.1%Triton X-100, 0.05%DOCand 150mMNaCl, 0.5mMPMSF), AGO1 antibody
(Wako, Clone 2A7) and rotated overnight on a rocker wheel at 4oC. Immuno-complexes were captured with Dyna beads Protein G
(Invitrogen) for 2 hrs on a rocker wheel at 4C. Further, beads were washed with 2X Low Salt buffer (20 mM Tris/HCl pH 8.0, 2 mMCell Systems 9, 446–458.e1–e6, November 27, 2019 e3
EDTA, 0.1% SDS, 1% Triton X-100, 150 mM NaCl, 0.5 mM PMSF), 2X High Salt buffer (20 mM Tris/HCl pH 8.0, 2 mM EDTA, 0.1%
SDS, 1% Triton X-100, 500 mM NaCl, 0.5 mM PMSF), 1X LiCl buffer (10 mM Tris/HCl pH8.0, 10 mM EDTA, 1% NP-40, 250 mM LiCl,
0.5mMPMSF), and 1X TE (1mMTris/HCl pH 8.0, 1mMEDTA). Finally, immunocomplexes were eluted (1mMTris/HCl pH 8.0, 10mM
EDTA, 1% SDS) at 65C for 20 min, cross-links were reversed at 65C overnight, treated with RNase A, proteinase K and then
DNA was extracted with Phenol:Chloroform:Isoamyl alcohol (25:24:1). The extracted ChIP-DNA (using ChIP-DNA Clean & Concen-
trator, Zymo) was processed for high-throughput library preparation (TruSeqChIP Library Preparation Kit, illumina). TheChIP libraries
were purified using Ampure XP beads and were quantified using qubit dsDNA HS assay kit.
For ChIP experiment after actinomycin D treatment. HepG2 cells were treated with actinomycin D (1.6 mM) or DMSO (as a control)
for 6 hour before collecting for fixation.
Stable FLAG- HA-tagged AGO1 HepG2 Cell Lines
Stable HepG2 cell lines expressing AGO1 proteins fused to C-terminal FLAG and HA epitope tags were generated using retroviral
vector (pOZ-FH-C-puro, Addgene plasmid # 32516) (Kumar et al., 2009). The FLAG-HA-tagged AGO1 was immunoprecipited by
HA-antibody (Abcam, # ab9110) for ChIP experiment as mentioned above.
AGO1 RIP from Chromatin Fraction
The AGO1 RIP-seq was performed following the above ChIP experiment until the last washing step as described in the protocol. The
whole procedure was carried out at 4C and all the buffers were prepared in DEPC (0.1 % (v/v) and supplemented with Superase-In
(Ambion–AM2696) 10U/ml. After proteinase K treatment (0.4 mg/ml) on beads at 37C for 30min, the samples were processed for the
reverse cross-linking at 65C for 2 hrs. Finally, the RNAs were extracted using TRI reagent and processed for library preparation
(TruSeq Stranded Total RNA Library, Illumina). The RIP-seq libraries were prepared from two replicates of chromatin-bound
AGO1 associated RNAs and mock sample RNAs (control) for 100 and 400 fragment sizes. Raw sequencing reads were aligned to
the UCSC human genome release hg19 using tophat2 (v2.0.14). In order to identify enriched peaks, the target and mock reads
for each fragment size and for each replicate independently were first aligned. They were then used as input for piranha (v1.2.1)
(Uren et al., 2012) with the following command-line options "-s -l". Only consistent peaks, identified through genomic overlap of
at least 1 base were retained using BEDTools (Quinlan and Hall, 2010). Figures were generated using R and ggplot2.
RT-qPCR
Extracted RNA samples were reverse transcribed using the QuantiTect reverse transcription kit (Qiagen, Cat # 205311). cDNA from
RNA and ChIP-DNAwere amplified by quantitative PCR on CFX96 Real-Time PCRMachine (Bio Rad) using the SYBR Select Master-
mix (Applied Biosystems, Waltham, Massachusetts, United States of America). For gene expression normalization, the geometric
mean of 18S rRNA, GAPDH, and Actin-B mRNA levels, were used. For primers detail see Table S5.
Preparation of Hi-C Libraries and Generation of Contact Matrices
Hi-C experiment was carried out as previously described (Lieberman-Aiden et al., 2009; Belton et al., 2012), with minor modifications
(Schoenfelder et al., 2015). Briefly, 25 million cells were fixed with 2% formaldehyde and lysed. Following HindIII digestion and bio-
tinylation of DNA ends (Biotin-14-dATP), ligation was performed using T4-DNA ligase inside the nuclei. After de-crosslinking the DNA
was purified, sheared and pull-down with streptavidin beads. Hi-C libraries were prepared for sequencing on HiSeq 4000 (Illumina).
After sequencing Fastq data were processed through HiC-Pro pipeline (Servant et al., 2015) for generating contact matrices at
different resolutions (1Mb, 150kb, 100kb and 20kb). We obtained a total of around 190 million valid interaction pairs, 95 million
for siCtrl and 95 million for siAGO1 HepG2 cells (combined replicates) (Figures S7A–S7D), the two replicates in each condition
showed high degree of similarity and reproducibility (Figure S7E).
Small RNA-seq
The small RNA-seq libraries were generated from total RNA with three replicates in each condition (siCtrl and siAGO1 HepG2) using
Illumina TruSeq small RNA protocol. These libraries were sequenced on Illumina HiSeq2000. After QC and trimming of low quality
bases and adapters, the fastq files were uploaded to the online small RNA-seq analysis tool Oasis 2.0 (https://oasis.dzne.de) (Rah-
man et al., 2018) for detection, differential expression, and classification of small RNAs.We identified a list of significant (p-value 0.01)
differentially expressed miRNAs. For integration with CAGE-seq data, we used the mirTarBase tool (mirtarbase.mbc.nctu.edu.tw/
php/) (Chou et al., 2018) to identify the targets of differentially expressed miRNAs in the list of differentially expressed genes from
AGO1 knockdown CAGE-seq data.
Bioinformatics Analyses
CAGE-seq Data Analysis
The CAGE libraries were generated using RNA extracted either from chromatin or total fraction with three replicate in each condition
(siCtrl and siAGO1 HepG2). These libraries were sequenced using HiSeq2000 with each single read of 50-bp length. The low quality
bases and adapter were trimmed using cutadapt tool. The clean reads were then mapped on to the human reference genome hg19
from UCSC. To get the tag counts that mapped on to the genomic loci, the mapped bam files were analyzed using the R packagee4 Cell Systems 9, 446–458.e1–e6, November 27, 2019
CAGEr (https://bioconductor.org/packages/release/bioc/html/CAGEr.html). Expression tables were generated by counting the
number of mapped reads within 500 bases of an UCSC (http://hgdownload.cse.ucsc.edu/goldenPath/hg19) annotated 5 prime
ends as expression from the transcript in CAGE. The number of tags for each sample was used as input counts and uploaded to
the DESeq2 a Bioconductor package (https://bioconductor.org/packages/release/bioc/html/DESeq2.html) for differential gene
expression calculation. The up and down regulated genes were tabulated with a significance FDR threshold of 0.05.
For enhancer RNAs (eRNAs) identification, CAGE expression (chromatin and total) data was used as described previously (Ander-
sson et al., 2014). The CAGE identified enhancer loci were then used for downstream analysis. The common CAGE predicted eRNAs
between siCtrl and siAGO1 cells were selected. These common eRNAs (tpm) were then used for comparison of expression dynamics
between siCtrl and siAGO1 cells using heatmapper (Babicki et al., 2016).
To identify CAGE-defined eRNAs that overlap with AGO1-bound enhancer regions, eRNA loci were intersected with AGO1 ChIP-
seq peaks using bedtools intersection (Quinlan and Hall, 2010). Similarly, intersection with ENCODE ChIP data sets (H3K4me1 and
H3K27ac) and HepG2 GRO-seq (Bouvy-Liivrand et al., 2017) was performed. Some randomly selected eRNAs that overlapped with
all data sets (ChIP-seq: AGO1, H3K4me1, H3K27ac and GRO-seq peaks) were further validated qPCR analysis in control and acti-
nomycin D treated cells.
ChIP-seq Data Analysis
After sequencing ChIP-seq reads of quality score less than 20 and length of 30bp were removed using sickle (http://www.citeulike.
org/user/mvermaat/article/13260426). We aligned the reads to the human genome assembly GRCh37 (hg19) using Bowtie (Lang-
mead and Salzberg, 2012) (version 2.2.5) with default parameters, and results were converted to sorted bam using samtools (Li
et al., 2009) (version 1.2). HMCan peak calling tool (Ashoor et al., 2013) was used for ChIP-seq peak calling. This tool is used for can-
cer cells to normalize reads for GC and copy number variation. Peak calling was then followed by irreproducibility discovery rate (idr)
analysis (Li et al., 2011). For peaks annotation, we used GENCODE (Harrow et al., 2012) (version19) annotation of the genome. ChIP-
seq peaks were annotated using Bedtools (Quinlan and Hall, 2010) and BEDOPS (Neph et al., 2012). Gene expression wasmeasured
as the sum of normalized CAGE tags within 500 pb from TSS. For integration with ChIP-seq, CAGE signals around ChIP-seq peaks
were computed using bwtools (Pohl and Beato, 2014) (version 2.17).
Hi-C Data Analysis
Differential Interaction Analysis
Genome-wide Hi-C matrices were loaded to the R package diffHiC (Lun and Smyth, 2015) (version 1.6.0) to identify differential in-
teractions between siAGO1 and siCtrl cells at different resolutions. Those interacting pairs of bins with an average read count
less than 5 (considering all replicates) were filtered out. The LOESS method was used to normalise counts between libraries. The
interacting pair of bins with a FDR value smaller than 0.05 were considered significant.
Identification of Topologically Associated Domains (TADs)
Columns with low number of counts in the genome-wide Hi-C matrices at 100 kbp resolution were filtered out using TADbit (version
0.2.0.23) (Serra et al., 2017) setting the parameter ‘‘min_count’’ to 10. Since TADbit fits the column count distribution into a polynomial
distribution, columns with a number of counts smaller than the first antimode of the distribution, which cannot be smaller than the
‘‘min_count’’ parameter, are filtered out. Then, 100 kbp genome-wide matrices were normalized by visibility (1 iteration of ICE). After-
wards, the breakpoint detection algorithm of TADbit that returns the optimal segmentation of the chromosome under BIC-penalized
likelihood was applied in order to identify Topologically Associating Domains (TADs). Hi-C matrices at 40 kbp resolution were pro-
cessed per chromosome instead of genome-wide.
Identification of Compartments
For compartment profiling, first columns with low number of counts in the genome-wide Hi-C matrices at 100-kbp resolutions were
filtered out using TADbit (version 0.2.0.23) setting the parameter ‘‘min_count’’ to 10. Then, 100 kbp genome-wide matrices were
normalized by the expected interactions at a given distance and by visibility (1 iteration of ICE). The correlation analysis was per-
formed with TADbit tool to obtain the first eigenvector. In-house scripts computed A/B compartments from the first eigenvector, us-
ing 0 as threshold to differentiate both compartments and genes with a basemean expression higher than 20 as active marks to label
compartments. Hi-C matrices at 40-kbp resolutions were processed per chromosome instead of genome-wide.
Heatmaps and Multi-Track Plots
The raw and normalized corrected matrices were plotted using hicPlotMatrix of HiCExplorer (version 1.3) (http://hicexplorer.
readthedocs.io/en/latest/index.html). Corrected matrices underwent a low-count bin filtering and ICE normalization (500 iterations)
prior to plotting. Multi-track plots were generated using HiCExplorer hicPlotTADs.
TAD Compartment Switching
TADs identified in siCtrl cells were intersected using the bedtools intersect with the first eigenvector of siCtrl and siAGO1 cells. Pos-
itive eigenvector values were attributed to A compartments, while negative eigenvector values were attributed to B compartments.
For each TAD and condition, the mean of the values of the corresponding eigenvector was calculated. TADs having a change in the
sign of the calculated means were designated as TADs that switched compartments.Cell Systems 9, 446–458.e1–e6, November 27, 2019 e5
QUANTIFICATION AND STATISTICAL ANALYSIS
All NGS data were analyzed using specific pipelines with statistical setting described in the STAR Methods. The significance of sta-
tistical analyses was computed either with Permutation tests, Mann–Whitney–Wilcoxon test, or t test. The quantification and statis-
tical details (p value and FDR thresholds, and the value of n) of each analysis can be found in the respective figure legends, Method
Details, and within the main manuscript.
DATA AND CODE AVAILABILITY
The high throughput sequencing data including CAGE-seq, ChIP-seq, small RNA-seq and Hi-C-seq have been deposited at the
Sequence Read Archive (SRA, http://www.ncbi.nlm.nih.gov/sra/), which is hosted at the NCBI, under the accession number SRA:
PRJNA398595. The AGO1 RIP-seq (chromatin-bound) data has been deposited at SRA under the accession number SRA:
PRJNA543746.e6 Cell Systems 9, 446–458.e1–e6, November 27, 2019
